No association between Parkinson's disease and low-activity alleles of catechol O-methyltransferase

Biochemical and Biophysical Research Communications

Volumn 228, Issue 3, 1996, Pages 780-784

  Hoda, Farzana ^a   Nicholl, David ^b   Bennett, Philip ^b   Arranz, Maria ^a   Aitchison, Katherine J ^a   Al Chalabi, Ammar ^a   Kunugi, Hiroshi ^a   Vallada, Homero ^a   Leigh, P Nigel ^a   Chaudhuri, K Ray ^a   Collier, David A ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOL METHYLTRANSFERASE;

ALLELE; ARTICLE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; PARKINSON DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 0008899828     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.1996.1731     Document Type: Article

References (30)

1. 1. Javoy-Agid, F., Hirsch, E. C., Dumas, S., Duyckaerts, C., Mallet, J., and Agid, Y. (1990) Neuroscience 38, 245-253.
2. 2. Armstrong, M., Daly, A. K., Cholerton, S., Bateman, D. N., and Idle, J. (1992) Lancet 339, 1017-1018.
3. 3. Smith, C. A., Gough, A. C., Leigh, P. N. et al. (1992) Lancet 340, 64-66.
4. 4. Trevor, A. J., Singer, T. P., Ramsay, R. R., and Castagnoli, N. Jr. (1987) J. Neural. Transm. Suppl. 23, 73-89.
5. 5. Schapira, A. H., Mann, V., Cooper, J. M., Dexter, D., Daniel, S. E., Jenner, P., Clark, J. B., and Marsden, C. D. J. (1990) Neurochemistry 55, 2142-2145.
6. 6. Degl'Innoccenti, F., Maurello, M. T., and Marini, P. (1989) Ital. J. Neurol. Sci. 10, 307-310.
7. 7. Gasser, T., Wszolck, Z. K., Trotfatter, J., Ozelius, L., Uitti, R. J., Lee, C. S., Gusella, J., Pfeiffer, R. F., Calne, D. B., and Breakefield, X. O. (1994) Ann. Neurol. 36, 387-396.
8. 8. Golbe, L. L, Di Iorio, G., Bonavita, V., Miller, D. C., and Duviosin, R. C. (1990) Ann. Neurol. 27, 276-280.
9. 9. Lloyd, K. G., Davidson, L., and Hornykiewicz, O. (1975) J. Pharmacol. Exp. Ther. 195, 453-464.
10. 10. Axelrod, J., and Tomchik, J. (1958) J. Biol. Chem. 233, 702-705.
11. 11. Goldstein, M., and Leiberman, A. (1992) Neurology 42 (suppl 4), 8-12.
12. 12. Mannisto, P. T., and Kaakkola, S. (1989) Trends Pharmacol. Sci. 10, 54-56.
13. 13. Kaakkola, S., Teravainen, H., Ahtila, S., Rita, H., Gordin, A. (1994) Effect of entacapone, a COMT inhibitor, on clinical disability and levodopa metabolism in Parkinsonian patients. Neurology 44, 77-80.
14. 14. Huebert, N. D., Palfreyman, M. G., Haegele, K. D. (1983) Drug Metab. Dispos. 11, 195-200.
15. 15. Tenhunen, L., Salminen, M., Lundstrom, K., Kiviluoto, T., Savolainen, R., and Ulmanen, I. (1994) Eur. J. Biochem. 223, 1049-1059.
16. 16. Grossman, M. H., Szumlanski, C., Littrell, J. B., Weinstein, R., and Weinshilboum, R. M. (1992) Life Sci. 50, 473-480.
17. 17. Lotta, T., Vidgren, J., Tilgman, C., Ulmanen, I., Melen, K., Julkunen, I., and Taskinen, J. (1995) Biochemistry 34, 4202-4210.
18. 18. Daniel, S. E., and Lees, A. J. (1993) J. Neural. Trans. Suppl. 39, 165-172.
19. 19. Lincoln, S. E., Daly, M. J., and Lander, E. The Whitehead Institute for Medical Research, Massachusetts, USA.
20. 20. Sykes, B. (1983) Lancet, ii, 787-788.
21. 21. Patel, P., Lo, Y. M. D., Bell, J. I., and Wainscoat, J. S. (1993) J. Clin. Path. 46, 1105-1108.
22. 22. Ott, J. (1985) Genet. Epid. 2, 79-84.
23. 23. Kurth, J. H., and Kurth, M. C. (1992) Mov. Disorders 7, 290.
24. 24. Plante-Bordeneuve, V., Davis, M. B., Maraganore, D. M., Marsden, C. D., and Harding, A. E. (1994) Mov. Disorders 9, 337-339.
25. 25. Kurth, J. H., Kurth, M. C., Poduslo, S. E., and Schwankhaus, J. D. (1993) Ann. Neurol. 33, 368-372.
26. 26. Ho, S. L., Kapadi, A. L., Ramsden, D. B., and Williams, A. C. (1995) Ann. Neurol. 37, 403-405.
27. 27. Hotamisligil, G. S., Girmen, A. S., Fink, J. S., et al. (1994) Mov. Disorders 9, 305-310.
28. 28. Rivera-Calimlim, L., and Reilly, D. K. (1984) Clin. Pharmacol. Ther. 35, 804-809.
29. 29. Klemetsdal, B., Straume, B., Giverhaug, T., and Aarbakke, J. Eur. J. Clin. Pharmacol. 46, 231-235.
30. 30. Reilly, D. K., Hershey, L., Rivera-Calimlim, L., and Shoulson, I. (1993) Adv. Neurol. 37, 51-60.